KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Taxes (2016 - 2025)

Edwards Lifesciences has reported Change in Taxes over the past 12 years, most recently at $57.6 million for Q4 2025.

  • Quarterly results put Change in Taxes at $57.6 million for Q4 2025, up 111.79% from a year ago — trailing twelve months through Dec 2025 was -$141.8 million (up 24.05% YoY), and the annual figure for FY2025 was -$141.8 million, up 24.05%.
  • Change in Taxes for Q4 2025 was $57.6 million at Edwards Lifesciences, up from -$10.2 million in the prior quarter.
  • Over the last five years, Change in Taxes for EW hit a ceiling of $671.8 million in Q3 2024 and a floor of -$488.5 million in Q4 2024.
  • Median Change in Taxes over the past 5 years was -$2.2 million (2021), compared with a mean of -$13.9 million.
  • Biggest five-year swings in Change in Taxes: tumbled 805.17% in 2022 and later surged 792.16% in 2024.
  • Edwards Lifesciences' Change in Taxes stood at $33.0 million in 2021, then tumbled by 143.64% to -$14.4 million in 2022, then plummeted by 678.47% to -$112.1 million in 2023, then crashed by 335.77% to -$488.5 million in 2024, then soared by 111.79% to $57.6 million in 2025.
  • The last three reported values for Change in Taxes were $57.6 million (Q4 2025), -$10.2 million (Q3 2025), and -$240.4 million (Q2 2025) per Business Quant data.